资讯

Citius Oncology Deploys AI Platform to Amplify the Performance of its Commercial Team Ahead ...

Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc.

Citius Oncology部署人工智能平台支持LYMPHIR上市

新泽西州 - Citius Oncology, Inc. (NASDAQ: CTOR )周五宣布，该公司已实施一个人工智能平台，以增强其商业运营，为预期推出的皮肤T细胞淋巴瘤 (CTCL)治疗药物LYMPHIR做准备。母公司Citius Pharmaceuticals (NASDAQ: CTXR )目前交易价格为$1.23，根据 InvestingPro ...

爸爸带娃丝滑漂移，动作简直太丝滑，宝宝：你觉得我想玩吗

爸爸带娃丝滑漂移，动作简直太丝滑，宝宝：你觉得我想玩吗 ...
Moneylife2 天

SEBI Imposes Rs2 Lakh Penalty on SMC Global Securities for Unauthorised Trading Terminals

Markets regulator Securities and Exchange Board of India (SEBI) has imposed a penalty of Rs2 lakh on SMC Global Securities ...
/Film on MSN1 天

The Only Major Actors Still Alive From The A-Team Series

The A-Team is over 40 years old, and sadly some of the cast members are no longer with us, but here are the show's major ...
Zacks Small Cap Research on MSN4 天

SNGX: Dusquetide (SGX945) Granted Orphan Drug Designation for Behcet’s Disease

SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Dusquetide (SGX945) Granted Orphan Drug Designation for the Treatment ...

5 Healthcare Stocks On Fire This Week

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech & pharma.

HDAC Inhibitors Market Sees Upward Trajectory Across the 7MM During the Forecast Period ...

DelveInsight's HDAC Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...
The Manila Times5 天

Equinor ASA: Buy-back of shares to share programmes for employees

Please see below information about transactions made under the buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR) for ...

Behcet’s Disease Market Outlook 2034 – Clinical Trials, Market Size, Medication ...

DelveInsight’s report, “Behcet’s Disease Market Insights, Epidemiology, and Market Forecast – 2034” provides a comprehensive ...